| PARAMETER |
GROUP I |
GROUP II |
GROUP III |
GROUP IV |
| HEMOGLOBIN( g/dl) |
14.7±1.92 |
*9.19±1.54 |
13.34±1.30 |
**9.44±1.81 |
| IRON (µ/dl) |
93±30 |
*58±19 |
*114.79±18.8 |
**68.52±19.63 |
| TIBC (µ/dl) |
337±56 |
*362±64 |
318.87±73.14 |
315.12±56.33 |
| TRANSFERRIN SATURATION % |
28±9.3 |
*16.74±6.29 |
*38.19±11.50 |
**22.24±7.65 |
| FERRITIN (ng/ml) |
55.5±22 |
*17±4.3 |
*103.67±50.09 |
**37.92±23.91 |
| TRANSFERRIN (ng/ml) |
308±22 |
*339±18 |
*348.61±24.93 |
350.08±29.32 |
| INSULIN (µU/ml) |
15.23±2.67 |
*8.67±2.67 |
*24.98±21.35 |
**19.09±12.37 |
| HbA1C (%) |
5.72±0.63 |
5.17±1.06 |
*7.85±2.24 |
**6.46±2.07 |
| FASTING BLOOD SUGAR (mg/dl) |
84.3±8.75 |
*69.91±11.84 |
*159.53±87.63 |
**120.9±31.30 |
| HOMA IR |
1.81±0.66 |
1.68±0.46 |
*11.6±10.46 |
**5.95±5.13 |
| HOMA B |
172.40±79 |
*48.52±16 |
*58.38±45.43 |
55.49±34.09 |
| INTERLUKIN-6 (ng/ml) |
4.5±3.5 |
6.54±4.6 |
3.36±2.66 |
**19.30±7.96 |
| TUMOR NECROSIS FACTOR ALPHA (ng/ml) |
10.5±5.39 |
14.28±4.7 |
*29.06±8.90 |
**24.33±19.89 |
| *TOTAL ANTIOXIDATION CAPACITY (mMol/L) |
7.38±2.4 |
*4.01±1.13 |
*3.43±0.89 |
3.78±1.21 |
MITOCHONDRIAL
OXIDATIVE CAPACITY
( nMol/min/ml) |
465±187 |
*158±65 |
*204±63 |
179±70 |
Data calculated as mean ± SD
Group I: Controls
Group II: IDA
Group III: T2DM without IDA
Group IV: T2DM with IDA
*: P<0.05(significant) Group II and Group III as compared with Group I
**: P<0.05(significant) Group IV as compared with Group III |
